The STADA Bone Health Hub contains information and bone health resources that aim to support Healthcare Professionals in preventing fractures and preserving NHS resources.
Every minute, someone in the UK suffers a fragility fracture.1
With osteoporotic fracture costs already £4.7 billion each year, the burden on the NHS is set to increase markedly as the population ages.1,2
For patients too, the consequences can be devastating. Hip and vertebral fractures tend to have the most worrying repercussions, but fractures at any site can impact on survival.3,4
Since there is no clinical specialty dedicated solely to bone health, sharing essential knowledge and tools to support the provision of optimal care for patients assumes particular importance.
That’s where our STADA Bone Health Hub fits in. As well as providing you with information on our four treatments spanning the bone health patient pathway, you will find clinical and patient guides, access to HCP educational webinars and our Bone Health Algorithm, a useful tool that aims to provide a framework to aid decision-making around treatments, developed in conjunction with the Royal Osteoporosis Society.
Just scroll down to explore the hub.
Consequently, our portfolio of cost-effective bone health treatments spans the patient pathway from prevention and management of vitamin D deficiency through to treatment of osteoporosis and fracture prevention
Created in collaboration with the Royal Osteoporosis Society, this valuable tool establishes a structured framework to facilitate treatment decision-making. Supporting consistency across populations, the algorithm asks a series of questions to guide clinicians through a potential diagnosis of vitamin D deficiency and/or osteoporosis followed by a suggested treatment pathway. The aim is to optimise patient outcomes by delivering the appropriate treatment at the appropriate time in line with national NICE, SIGN and NOGG guidelines.Click Here
We are proud to be a partner of the Royal Osteoporosis Society.
For more information on the ROS’s mission, research academy, patient support and other initiatives, please click the link
For information on our products please visit EMC, https://www.medicines.org.uk/emc/ and search the product for a Summary of Product Characteristics
Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Thornton and Ross Limited by emailing firstname.lastname@example.org or by calling 01484 848164
UK-MULT-130(1) | Date of Preparation November 2023
Thornton & Ross is a member of the STADA Group © Copyright Thornton & Ross 2023